Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;118(1):106-109.
doi: 10.36660/abc.20210062.

Long-Term Cardiac Complications of PRKAG2 Syndrome

[Article in English, Portuguese]
Affiliations

Long-Term Cardiac Complications of PRKAG2 Syndrome

[Article in English, Portuguese]
Luiz Pereira de Magalhães et al. Arq Bras Cardiol. 2022 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potencial conflito de interesse

Não há conflito com o presente artigo

Figures

Figura 1
Figura 1. Heredograma da família. Indivíduos testados quanto à mutação do PRKAG2: (+) portadores; (-) não portadores da mutação. MP: marca-passo; CDI: cardioversor-desfibrilador implantável; MS: morte súbita.
Figura 2
Figura 2. A) Eletrocardiograma da paciente III:8 mostrando pré-excitação ventricular e morfologia de bloqueio de ramo direito. B) Estudo eletrofisiológico. Intervalo HV= 30 ms. Eletrogramas, A: atrial; H: His; V: ventricular.
Figura 3
Figura 3. Método de Kaplan-Meier: incidência cumulativa de complicações cardiovasculares (implante de marca-passo ou morte súbita).
Figure 1
Figure 1. Genogram of the family. Individuals tested for a PRKAG2 mutation: carriers (+) or non-carriers (-). PM: pacemaker; ICD: implantable cardioverter-defibrillator; SD: sudden death.
Figure 2
Figure 2. A) Electrocardiogram of patient III:8 showing ventricular pre-excitation, and right bundle branch block morphology. B) Electrophysiology study of the same patient. HV interval= 30 ms. Electrograms, A: atrial; H: His bundle; V: ventricular.
Figure 3
Figure 3. Kaplan-Meier curve of the cumulative incidence of cardiovascular events (pacemaker implantation or sudden death).

References

    1. Porto AG, Brun F, Severini GM, Losurdo P, Fabris E, Taylor MRG, et al. Clinical Spectrum of PRKAG2 Syndrome. Circ Arrhythm Electrophysiol. 2016;9(1):e003121. doi: 10.1161/CIRCEP.115.003121. - PMC - PubMed
    1. Zhang LP, Hui B, Gao BR. High Risk of Sudden Death Associated with a PRKAG2-Related Familial Wolff-Parkinson-White Syndrome. J Electrocardiol. 2011;44(4):483-6. doi: 10.1016/j.jelectrocard.2010.02.009. - PubMed
    1. Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS, et al. Identification of a Gene Responsible for Familial Wolff-Parkinson-White Syndrome. N Engl J Med. 2001;344(24):1823-31. doi: 10.1056/NEJM200106143442403. - PubMed
    1. Arad M, Benson DW, Perez-Atayde AR, McKenna WJ, Sparks EA, Kanter RJ, et al. Constitutively Active AMP Kinase Mutations Cause Glycogen Storage Disease Mimicking Hypertrophic Cardiomyopathy. J Clin Invest. 2002;109(3):357-62. doi: 10.1172/JCI14571. - PMC - PubMed
    1. Sternick EB, Oliva A, Magalhães LP, Gerken LM, Hong K, Santana O, et al. Familial Pseudo-Wolff-Parkinson-White Syndrome. J Cardiovasc Electrophysiol. 2006;17(7):724-32. doi: 10.1111/j.1540-8167.2006.00485.x. - PubMed

Substances

LinkOut - more resources